What question did this study set out to answer?

This research explores the potential and obstacles of using 3D printing for personalized drug delivery systems.

April 14, 2026

3D printed drug delivery devices: recent promises and challenges

Puntos clave

This research explores the potential and obstacles of using 3D printing for personalized drug delivery systems.
Review of current literature on 3D printing applications in drug delivery.
Analysis of regulatory barriers and scalability challenges in clinical settings.
Discussion on the integration of AI/ML in 3D printing for adaptive manufacturing.
Identified key challenges in scalability and regulation for clinical adoption of 3D printed devices.
Highlighted the potential of AI-driven tools to enhance manufacturing processes.
Emphasized the importance of bio-responsive materials in improving therapeutic effectiveness.

Resumen

Although 3DP offers patient-tailored, on-demand products, its clinical adoption is hindered by regulatory barriers, limited standards, and scalability issues. Integrating AI/ML could offer real-time adaptive clinical manufacturing; however, the guidelines for these disruptive technologies are often unclear. With patient-centric manufacturing, 3D-printed devices and scaffolds could play a key role in personalized medicine, delivering targeted and effective therapies.The transition from proof-of-concept to real-world testing underscores the growing feasibility and clinical relevance of 3DP technologies. With rapid progress in bio-responsive materials and AI-driven design tools, 3D-printed delivery platforms are expected to improve in adaptability and therapeutic effectiveness for next-generation personalized therapies.

Preguntar a la IA

Me gusta

Guardar